The Effects of Visior on Ocular Hemodynamics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the relationship between the affects of viewing commercially available content through the VISIOR video goggles and ocular blood flow in glaucoma patients and healthy subjects.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Correlation of Structure and Function in Glaucoma

NCT05954637

Glaucoma

COMPLETED

The Study of Ocular Hemodynamics With Glaucoma Progression

NCT01145911

Glaucoma

COMPLETED

Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients?

NCT02526680

Glaucoma

COMPLETED NA

Use of an Ocular Telemetry Sensor in Diamox Treated Patients

NCT01028664

Glaucoma Ocular Hypertension

COMPLETED NA

Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients

NCT01849536

Open Angle Glaucoma With a Progressive Visual Field

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To determine if glaucoma patients and healthy subject experience any alteration in localized retinal blood flow after retinal stimulation by viewing commercially available content through the VISIOR video goggles.

Both groups will undergo measurements of arterial blood pressure, cardiac pulse (heart rate), intraocular pressure, and retinal blood flow using Heidelberg retinal flowmetry (Heidelberg Engineering, Heidelberg, Germany) at baseline and then ten minutes, thirty minutes, and sixty minutes after viewing commercially available content through the VISIOR video goggles for thirty minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Open Angle Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Glaucoma patients

To view commercially available content through the VISIOR video goggles for thirty minutes

Group Type EXPERIMENTAL

VISIOR video goggles

Intervention Type DEVICE

View commercially available content through the VISIOR video goggles continuously for thirty minutes.

Healthy subjects

To view commercially available content through the VISIOR video goggles for thirty minutes.

Group Type EXPERIMENTAL

VISIOR video goggles

Intervention Type DEVICE

View commercially available content through the VISIOR video goggles continuously for thirty minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VISIOR video goggles

View commercially available content through the VISIOR video goggles continuously for thirty minutes.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with open-angle glaucoma 30 years or older, free from other ophthalmic disease, free from diabetes, beta agonists and uncontrolled blood pressure.

Exclusion Criteria

* Women who are pregnant or lactating or who plan to become pregnant (self reporting); smoker during last ten years (self reporting); systemic diseases that may interfere with blood flow measurements or wearing the goggles.

Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes